Print

10-1074

Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074 Monoclonal Antibody in HIV-infected and HIV-uninfected Individuals

Trial Details:

I Ongoing
Rockefeller University July 01, 2015
10-1074 10-1074 Antibody
10-1074 Passive Immunization
Germany, USA 51
NCT02511990
https://clinicaltrials.gov/show/NCT02511990